UK markets open in 4 hours 48 minutes

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.91+0.12 (+0.81%)
At close: 04:00PM EDT
14.84 -0.07 (-0.50%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
656,665
556,382
1,598,951
197,581
22,388
-
Cost of revenue
368,891
343,768
902,639
0
0
-
Gross profit
287,774
212,614
696,312
197,581
22,388
-
Operating expenses
Research development
583,080
737,502
1,235,278
2,534,508
747,027
-
Selling general and administrative
443,212
468,946
488,691
298,358
145,290
-
Total operating expenses
686,348
779,125
1,341,048
1,884,157
439,107
-
Operating income or loss
-398,574
-566,511
-644,736
-1,686,576
-416,719
-
Interest expense
14,211
14,416
19,880
21,127
15,145
-
Total other income/expenses net
17,188
37,896
10,969
-6,833
13,605
-
Income before tax
-395,597
-543,031
-653,647
-1,714,536
-418,259
-
Income tax expense
3,110
2,031
4,292
29,215
0
-
Income from continuing operations
-398,707
-545,062
-657,939
-1,743,751
-418,259
-
Net income
-398,707
-545,062
-657,939
-1,743,751
-418,259
-
Net income available to common shareholders
-398,707
-545,062
-657,939
-1,743,751
-418,259
-
Basic EPS
-6.23
-
-8.42
-23.44
-7.27
-5.51
Diluted EPS
-6.23
-
-8.42
-23.44
-7.27
-5.51
Basic average shares
89,744
-
78,183
74,400
57,554
24,100
Diluted average shares
89,744
-
78,183
74,400
57,554
24,100